Related Experiment Video
Updated: May 23, 2026

09:26
Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells
Published on: February 20, 2015
Endothelial microparticles: missing link in endothelial dysfunction?
Pearly J A Yong1, Cai Hong Koh, Winston S N Shim
1SingHealth Research Facilities, Singapore.
European Journal of Preventive Cardiology
|April 13, 2012
Summary
Endothelial microparticles (EMPs) are key indicators of vascular health, reflecting endothelial function and playing roles in various diseases. Further research and standardization are needed for their clinical use in monitoring vascular conditions.
Area of Science:
- Vascular Biology and Endothelial Function
- Biomarkers and Diagnostics
- Pathophysiology
Background:
- Endothelial microparticles (EMPs) are vesicles released by the endothelium, reflecting its functional status.
- EMPs act as messengers in vascular inflammation, thrombosis, angiogenesis, and endothelial survival.
- Their presence is linked to endothelial dysfunction and various disease states.
Purpose of the Study:
- To review the evolving understanding of EMPs from passive vesicles to active messengers.
- To highlight the role of EMPs in cardiopulmonary, renal, cerebral, and metabolic disorders.
- To discuss the potential of EMPs as non-invasive biomarkers for vascular health.
Main Methods:
- Literature review of current evidence on EMPs.
- Analysis of EMPs' biological roles in endothelial function and disease.
- Discussion of technical challenges and standardization needs in EMP research.
Main Results:
- EMPs are increasingly recognized for their diverse biological roles.
- Evidence links EMPs to various systemic disorders, indicating endothelial dysfunction.
- Significant technical challenges in EMP detection and quantification persist.
Conclusions:
- EMPs are crucial in pathophysiological responses and reflect endothelial competency.
- Clinical validation of EMPs in various disorders is warranted.
- Standardized EMP analysis could lead to novel non-invasive surveillance platforms for vascular health and disease prognostication.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
